Picture of Gfc Life Science Co logo

388610 Gfc Life Science Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapFalling Star

Annual cashflow statement for Gfc Life Science Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsARSARSAnnual Audited Accounts
Standards:
KAS
KAS
KAS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,6173271,437-5,947555
Depreciation
Amortisation
Non-Cash Items-183150-8507,683-23.4
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-1,396-304162-352-881
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities9411,1251,7032,9671,367
Capital Expenditures-651-832-343-3,011-7,712
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items3,628-46927934791
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities2,977-1,301-64.3-2,664-7,621
Financing Cash Flow Items-7010
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-2,874-385-781-28412,183
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,044-56185854.75,932